뒤로
Serina Therapeutics Inc(SER) 가격
SER 주가 차트
SER 수입
Serina Therapeutics Inc
$2.87
-3.04%
$-0.08
종가: Jan 23, 16:00:00 GMT-5
$2.87
0%
$0
애프터마켓: Jan 23, 20:00:00 GMT-5
최신 수익 결과: Q3 '25
보고됨: 2025-11-13
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
SER의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Serina Therapeutics Inc SER의 지난 분기 매출 실적은 어땠나요?
Serina Therapeutics Inc의 매출 추정치는 얼마인가요?
Serina Therapeutics Inc의 수익 품질 점수는 얼마인가요?
Serina Therapeutics Inc는 언제 수익을 보고하나요?
Serina Therapeutics Inc의 예상 수익은 얼마인가요?
Serina Therapeutics Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$2.96
시가
$2.97
일일 범위
$2.72 - $3
52주 범위
$1.71 - $7.92
거래량
23.1K
평균 거래량
48.0K
EPS(TTM)
-1.66
배당수익률
--
시가총액
$30.5M
SER란 무엇인가요?
Serina Therapeutics, Inc. operates as a clinical-stage biotechnology company, which engages in the research and development of polymer technology. The company is headquartered in Huntsville, Alabama and currently employs 12 full-time employees. The company went IPO on 2018-11-29. The firm's POZ Platform provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Its proprietary POZ technology is based on a synthetic, water soluble, low viscosity polymer called poly(2-oxazoline). Its POZ technology is engineered to provide greater control in drug loading and more precision in the rate of release of attached drugs delivered via subcutaneous injection. SER-252 is the Company’s lead candidate for advanced Parkinson’s disease. SER-252 is an investigational apomorphine therapy developed with its POZ platform and designed to provide continuous dopaminergic stimulation.